Advanced Mismatch Repair-deficient (dMMR) Endometrial Cancer

DrugDrug NameDrug Description
DB15627DostarlimabAn anti-PD-1 monoclonal antibody used in the treatment of mismatch repair deficient endometrial cancers and solid tumours with no alternative treatment options.
DrugDrug NamePhaseStatusCount